| Lorraine L Langlais, RN, CDOE | |
|
11 Friendship St, Newport, RI 02840-2209 | |
| (401) 846-6400 | |
| Not Available |
| Full Name | Lorraine L Langlais |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Diabetes Educator |
| Location | 11 Friendship St, Newport, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033394754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WD0400X | Registered Nurse - Diabetes Educator | RN22768 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lorraine L Langlais, RN, CDOE 11 Friendship St, Newport, RI 02840-2209 Ph: (401) 846-6400 | Lorraine L Langlais, RN, CDOE 11 Friendship St, Newport, RI 02840-2209 Ph: (401) 846-6400 |
News Archive
The search for new measures, or "biomarkers," to detect Alzheimer's disease (AD) before signs of memory loss appear has advanced an important step in a study by researchers at Washington University in St. Louis, MO, and the University of Pittsburgh.
Babies with Hirschsprung's disease are born with an incomplete or absent gut nervous system. Children's Hospital Los Angeles investigator Tracy Grikscheit, MD, runs a laboratory that investigates the therapeutic potential of tissue engineering - the induced growth of healthy tissue using stem cells.
The effect of economic cuts on debt ravaged Greece included a dramatic rise in the number of men committing suicide, according to new research.
Nearly half (43.9%) of rheumatoid arthritis (RA) patients receiving tocilizumab 8mg/kg, in addition to ongoing methotrexate therapy experienced a 50% (ACR50) improvement in symptoms at 24 weeks and more than one fifth achieved a 70% symptom improvement, according to results of a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
› Verified 1 days ago
Laura E Nelson, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 19 Friendship Pl, Newport, RI 02840 Phone: 203-592-3682 | |
Erin Thomas, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6 John H Chafee Blvd, Newport, RI 02840 Phone: 401-848-2160 | |
Angela Maria Allen, RN, CDOE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6 John H Chafee Blvd, Newport, RI 02840 Phone: 401-848-2160 | |
Colton Cranson, Registered Nurse Medicare: Medicare Enrolled Practice Location: 292 Broadway, Newport, RI 02840 Phone: 401-200-2052 | |
Mrs. Judith Anne Byrnes, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Riggs Rd., Newport, RI 02841 Phone: 401-841-6774 | |
David Antico, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 34 Smith Rd, Newport, RI 02841 Phone: 401-841-4170 |